Valion Bio Appoints Lisa Wolf To Expanded Roles Of President, COO, Effective Immediately
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company, today announced strategic changes to its management team and Board of Directors designed to
Valion Bio moved Lisa Wolf into bigger leadership jobs right away. When a company gives someone more important roles, it can mean the leaders think that person will help the company do better things.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.